RIGL

Rigel Pharmaceuticals, Inc. News Headlines

$1.96
*  
0.05
2.62%
Get RIGL Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading RIGL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    RIGL Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog
8/14/2014 3:30:00 PM - Zacks.com


Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial
8/13/2014 1:00:25 PM - MT Newswires


Sector Update: Health Care
8/13/2014 12:59:38 PM - MT Newswires


Rigel Pharma Says Phase 2 Study For Dry Eye Disease Did Not Meet Endpoints
8/13/2014 9:34:00 AM - RTT News


Rigel Pharma: R348 Did Not Meet Endpoints In Phase 2 Dry Eye Study
8/13/2014 7:38:00 AM - RTT News


Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog
7/17/2014 4:45:00 PM - Zacks.com


Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape
4/11/2014 8:46:01 AM - Zacks.com


Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha


Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape
3/7/2014 10:46:01 AM - Zacks.com


Rigel Rises on Narrower Q4 Loss - Analyst Blog
3/6/2014 10:40:01 AM - Zacks.com


Pre-Market Earnings Report for March 4, 2014 : BNS, AZO, HTH, TSL, SSP, BRLI, TRIB, JRN, GTIV, MCGC, RIGL, RSH
3/3/2014 5:00:01 PM - NASDAQ.com News


Rigel Narrows Loss, Shares Continue to Fall - Analyst Blog
11/12/2013 4:05:32 PM - Zacks.com


Rigel Pharma Trims Workforce - Analyst Blog
9/10/2013 6:45:01 PM - Zacks.com


Sector Update: Healthcare Shares Lower; Rigel Plunges to New 52-Wk Low on Rationalization Plans
9/5/2013 8:08:18 AM - MT Newswires


Sector Update: Healthcare
9/5/2013 8:04:51 AM - MT Newswires


Rigel Down on Phase II Setback - Analyst Blog
8/27/2013 1:30:01 PM - Zacks.com


Yet Another Failure Has Rigel Pharmaceuticals Almost Back To Square One
8/26/2013 3:15:00 PM - Investopedia


Rigel Pharma Narrows Q2 Loss - Analyst Blog
8/7/2013 11:41:00 AM - Zacks.com


AstraZeneca to Return Fostamatinib Rights - Analyst Blog
6/5/2013 5:28:45 PM - Zacks.com


Pre-Market Most Active for Jun 4, 2013 : ET, ING, NOK, ZNGA, ASML, BAC, UBS, MTU, RIGL, GRFS, QQQ, INFI
6/4/2013 8:39:59 AM - NASDAQ.com News


A Journey To Add Biotech To The Portfolio
5/18/2013 2:38:00 AM - Seeking Alpha


Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog
5/9/2013 10:00:01 AM - Zacks.com


AZN Reports Data on Fostamatinib - Analyst Blog
4/8/2013 7:08:59 PM - Zacks.com


Small Pharma Watch List: Week Of April 8, 2013
4/8/2013 11:03:00 AM - Seeking Alpha